Related Experiment Video
Updated: Jul 17, 2026
12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cyclin-dependent kinases and stroke
Fuhu Wang1, Michael J O'Hare, David S Park
1Neuroscience Research Institute, Univ. of Ottawa, Ottawa, ON K1H 8M5, Canada. dpark@uottawa.ca
Expert Opinion on Therapeutic Targets
|January 24, 2003
Summary
Cyclin-dependent kinases (CDKs) regulate cell cycles but also neuronal death. This review explores CDK involvement in neuron death and their potential as stroke therapeutics.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Cyclin-dependent kinases (CDKs) are primarily known for regulating cell cycle progression in dividing cells.
- Emerging research indicates CDKs also play a critical role in promoting neuronal cell death.
- This dual role suggests CDKs as potential targets for neurological disorders.
Purpose of the Study:
- To review the evidence linking CDKs to neuronal death.
- To evaluate the therapeutic potential of CDK inhibitors for stroke treatment.
Main Methods:
- Literature review of studies investigating CDK function in neurons.
- Analysis of research on CDK inhibitors in the context of neuropathology.
Main Results:
- Evidence supports a role for CDKs in inducing neuronal apoptosis.
- CDK activity is implicated in the pathophysiology of stroke-induced brain damage.
Conclusions:
- CDKs are key mediators of neuronal death, particularly in stroke.
- Targeting CDKs with inhibitors presents a promising therapeutic strategy for stroke and other neuropathological conditions.
Related Concept Videos
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...